Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapies.

Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapies. J Autoimmun. 2017 Jul 16;: Authors: Bordignon C PMID: 28724503 [PubMed - as supplied by publisher] (Source: Journal of Autoimmunity)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uMfVZZ
via IFTTT